Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Home & Baby Companies Plan To Profit as Millennials Settle Down 08/28/14 Boston
HubSpot Files for IPO, On Pace for $100M in Revenue 08/25/14 Boston
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
6 Takeaways From Boston E-Commerce Firm Wayfair’s IPO Filing 08/15/14 Boston
Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim 08/13/14 National
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More 08/07/14 San Diego
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Easy Flights to Capital 07/14/14 Boston
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
San Diego’s Ambrx Withdraws IPO, Citing Market Conditions 06/30/14 San Diego
Boston Tech Roundup: Boston-Power, Imprivata, CloudLock, & More 06/13/14 Boston
Navigating JOBS, Wrangling Investors: A Biotech CFO Roundtable 05/27/14 National
Boston Tech Roundup: CRV, Mobiquity, Ditto Labs, Groupize 05/19/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs 05/02/14 San Diego
At Two-Year Mark, JOBS Act Is Regulation Even A Biotech Can Love 05/01/14 San Francisco
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
San Diego Life Sciences Roundup: Illumina, Vital Therapies, and More 04/24/14 San Diego
New Ignition Partners Happy Betting on Business Computing Renaissance 04/23/14 Seattle
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
Investing in Dreams: Northwest Programs Educate New Angels 04/14/14 Seattle
San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More 04/11/14 San Diego
Venture-Backed IPOs & Late-Stage Investments Surged in Q1 04/10/14 National
San Diego Life Sciences Roundup: Halozyme, NuVasive, Lumena, and More 04/07/14 San Diego
San Diego’s Lumena Files for IPO to Fund Liver Drug Trials 04/04/14 San Diego
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO 03/25/14 San Francisco
Page 1 of 16 next page »